GUERINI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 517
EU - Europa 301
AS - Asia 208
SA - Sud America 2
AF - Africa 1
Totale 1.029
Nazione #
US - Stati Uniti d'America 514
IT - Italia 81
PL - Polonia 66
SG - Singapore 61
DE - Germania 48
CN - Cina 39
HK - Hong Kong 39
FI - Finlandia 32
TR - Turchia 25
VN - Vietnam 20
GB - Regno Unito 18
UA - Ucraina 17
IE - Irlanda 16
ID - Indonesia 14
CZ - Repubblica Ceca 11
IN - India 5
SE - Svezia 3
CA - Canada 2
FR - Francia 2
NL - Olanda 2
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
RU - Federazione Russa 1
SL - Sierra Leone 1
UZ - Uzbekistan 1
Totale 1.029
Città #
Ashburn 69
Warsaw 66
Chandler 58
New York 57
Fairfield 52
Singapore 51
Hong Kong 38
Helsinki 29
Princeton 24
Boardman 22
Istanbul 22
Seattle 22
Dong Ket 20
Shanghai 20
Cambridge 16
Dublin 16
Jacksonville 16
Brescia 14
Houston 14
Jakarta 14
Wilmington 14
Woodbridge 13
Munich 12
Los Angeles 10
Brno 8
Ann Arbor 7
London 7
Rome 6
Beijing 5
Romola 5
San Diego 5
Pune 4
Washington 4
Cremona 3
Milan 3
Berlin 2
Bologna 2
Chiswick 2
Dalmine 2
Dearborn 2
Des Moines 2
Fort Worth 2
Guangzhou 2
Lappeenranta 2
Prague 2
Roseville 2
San Francisco 2
Siena 2
Toronto 2
Baku 1
Bishkek 1
Buenos Aires 1
Central 1
Changsha 1
Chicago 1
Cittadella 1
Colombo 1
Dallas 1
Delaware 1
Espoo 1
Falkenstein 1
Freetown 1
Groningen 1
Guayaquil 1
Gunzenhausen 1
Hanover 1
Hebei 1
Hefei 1
Hounslow 1
Jieyang 1
Jinan 1
Kilburn 1
Kocaeli 1
Latina 1
Leawood 1
Miami Beach 1
Minsk 1
Napa 1
Nave 1
Ningbo 1
Nuvolento 1
Pontirolo Nuovo 1
Prineville 1
Redwood City 1
San Mateo 1
Seoul 1
Sofia 1
Southwark 1
Stockholm 1
Taranto 1
Tashkent 1
Turin 1
Vienna 1
Wandsworth 1
Totale 819
Nome #
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 123
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 99
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 90
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 83
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 73
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 60
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum 51
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 45
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 44
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 44
Stratification of Oligometastatic Prostate Cancer Patients by Liquid Biopsy: Clinical Insights from a Pilot Study 41
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 39
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 38
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 37
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 27
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 22
The role of feature-based radiomics for predicting response and radiation injury after stereotactic radiation therapy for brain metastases: A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) 18
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 18
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 16
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 15
Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the 'radio talk' webinars 15
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 14
Prognostic role of baseline 18 F‐FDG pet/CT in squamous cell carcinoma of the paranasal sinuses 14
null 13
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 13
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 7
Totale 1.059
Categoria #
all - tutte 9.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202053 0 0 0 0 0 10 9 8 7 10 4 5
2020/2021241 8 5 28 22 20 17 22 18 21 34 15 31
2021/2022104 6 17 6 5 2 5 2 8 5 9 2 37
2022/2023172 19 7 8 7 19 37 3 17 25 4 19 7
2023/2024360 10 8 41 13 16 89 19 23 43 18 12 68
2024/2025129 6 17 16 86 4 0 0 0 0 0 0 0
Totale 1.059